Corporate Banner
Satellite Banner
Molecular & Clinical Diagnostics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

BD Launches Innovative Diabetes Pen Needle

Published: Thursday, March 27, 2014
Last Updated: Thursday, March 27, 2014
Bookmark and Share
BD Micro-Fine Ultra™ with Pentapoint 5-bevel technology helps to enhance patient comfort.

BD (Becton, Dickinson and Company) has announced the launch in the UK and Ireland of BD Micro-Fine Ultra™ with 5-bevel needle technology, clinically demonstrated to improve injection comfort for diabetes patients, and enhancing the injection advantages of the current BD Micro-Fine™+ Pen Needle.

A patient study found the five-bevel pen needles to be less painful, easier to insert and more comfortable, when compared with current three-bevel pen needles. This new Pentapoint™ 5-bevel technology is the next in a series of innovations to come from BD Medical - Diabetes Care, resulting in a BD Premium Pen Needle product line which will be called BD Micro-Fine Ultra™.

Studies suggest that as many as one-fifth to one-third of people with diabetes are hesitant or unwilling to give themselves insulin injections for reasons that include needle anxiety. Also, patients who reported injection-related pain or embarrassment intentionally skipped insulin injections more often.

The BD Micro-Fine Ultra™ Pen Needle with Pentapoint™ technology reduces skin penetration force by 23% on average, and is clinically demonstrated to reduce the pain of injection. This may help people with diabetes adhere to an insulin injection regimen and improve outcomes with greater comfort and ease of use.

The BD Micro-Fine Ultra™ with Pentapoint™ needle tip is specially designed with five-beveled edges to create a flatter, thinner surface to penetrate the skin with significantly greater ease, for a smoother and more comfortable injection experience, compared to previous generation three bevel needles. Pentapoint™ technology is available in 4mm pen needles.

Matthias Borst, VP / GM Europe, BD Medical - Diabetes Care, comments: “BD Diabetes Care has been a leader in diabetes injection devices for almost 90 years, and is committed to helping improve the injection experience for the millions of people living with diabetes, through ongoing patient education, the constant pursuit of innovation and improvement, and the development of high-quality products that make a difference. Building on the introduction of the BD Micro-Fine™+ 4mm Pen Needle in 2010, we are confident that our new Pentapoint™ technology will provide an even more comfortable injection experience, helping to minimize injection resistance, fear and anxiety in people with diabetes, enabling them more easily to adopt and adhere to the therapy regimens recommended to improve their diabetes care.”

The BD Micro-Fine Ultra™ 4mm Pen Needle is proven to be as effective as longer needles for patients of all body types, and provides equivalent glucose control by more effectively delivering the insulin dose to subcutaneous tissue (the layer of fat below the skin), the recommended site for insulin injections, and reducing the risk of injecting into muscle.

Intramuscular injection can accelerate insulin absorption and increase the risk of hypoglycemia (abnormally low blood sugar). Subcutaneous injection allows the insulin to be absorbed at an appropriate rate, resulting in better glycaemic control.

The BD Micro-Fine Ultra™ 4mm Pen Needle with Pentapoint technology has delivered a significant step forward in enhancing patient comfort and injection outcomes.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,400+ scientific posters on ePosters
  • More than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Tracking Breast Cancer Before it Grows
A team of scientists led by University of Saskatchewan researcher Saroj Kumar is using cutting-edge Canadian Light Source techniques to screen and treat breast cancer at its earliest changes.
The Light of Fireflies for Medical Diagnostics
EPFL scientists have exploited the light of fireflies in a new method that detects biological molecules without the need for complex devices and high costs.
Could a simple saliva test detect Alzheimer's?
Researchers have presented findings suggesting that a simple, non-invasive diagnostic for Alzheimer's could be within reach.
Cheap Diagnostics with a Portable "Paper Machine"
Scientists have developed a cheap, portable system for point of care diagnostics for a range of infectious diseases, genetic conditions and cancer.
New Variant of Streptococcal Bacteria
Scientists have discovered a new variant of streptococcal bacteria that has contributed to a rise in disease cases in the UK over the last 17 years.
New Insights into “Antenna” of Human Cells
Scientists from the University of Leeds have uncovered the most comprehensive list yet of genes implicated in a group of common inherited diseases.
Discordant NIPT Test Results May Reflect Presence of Maternal Cancer
Results published in Journal of the American Medical Association.
Sperm RNA Test May Improve Evaluation of Male Infertility
To help resolve uncertainty—and guide prospective parents to the right fertility treatments—scientists propose the use of a new kind of fertility test. It involves examining sperm RNA by means of next-generation sequencing.
Optical 'Dog's Nose' Developed to Detect Cancer, Other Diseases
Researchers are using optical spectroscopy to develop a quick, non-invasive “breath test” they believe will have the potential to screen for a variety of diseases, including diabetes, infections and cancers.
Ebola Assays Compared in Head-to-Head Analysis
A newly published study has attempted to rigorously evaluate a few of the assays recently granted Emergency Use Authorization by the US Food and Drug Administration to test for Ebola Zaire virus.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,400+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!